Ann: Dimerix to present at Melbourne Twilight Investor Briefing, page-50

I think we should be close to a $1 before the two big deals...and no reason shouldn't be $1.5-$2 once we sign the two deals..

The thing is that investors on ASX don't really understand how the entire drug approval and commercialization works..I was looking at some data for Neuron and it was surprising to see that the SP went up around 7-8X from the time Neuron got FDA approval and its commercial launch (Damn I didn't knew about Neuron until then)...post FDA approval, apart from extraordinary circumstances, the chances of a company not launching the drug is very small...

Post the FDA approval, given the TAM, I think we should be higher, much higher than NEU from a MC perspective, but I can't put a figure...

The other thing people need to understand that if our drug works, there will be a huge confidence boost in the Receptor-HIT technology and FSGS is just a start...